Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Increased hospitalizations in elderly with inflammatory bowel disease on anti-tumor necrosis factor therapy but not increased infections: a community practice experience.

Shen H, Lipka S, Katz S.

J Crohns Colitis. 2014 Aug;8(8):898-9. doi: 10.1016/j.crohns.2013.12.016. Epub 2014 Jan 14. No abstract available.

PMID:
24434182
2.

IBD: Can TNF inhibitors be administered during the third trimester?

Nielsen OH, Jess T.

Nat Rev Gastroenterol Hepatol. 2013 Mar;10(3):130-1. doi: 10.1038/nrgastro.2012.248. Epub 2012 Dec 18. No abstract available.

PMID:
23247511
3.

[Inflammatory bowel diseases--new therapeutic options].

Herrlinger K, Stange EF.

Med Klin (Munich). 2008 Feb 15;103(2):90-101; quiz 102-3. doi: 10.1007/s00063-008-1013-3. German. No abstract available.

PMID:
18270665
4.

[TNF-alpha blocking therapy in chronic inflammatory bowel disease].

Molnár T.

Orv Hetil. 2009 Sep 20;150(38):1773-9. doi: 10.1556/OH.2009.28689. Review. Hungarian.

PMID:
19740722
5.

The classics in perspective.

Panés J, Ghosh S.

Gut. 2007 Sep;56(9):1184-6. No abstract available.

6.

The safety of biologic agents in the treatment of inflammatory bowel disease.

Shepela C.

Minn Med. 2008 Jun;91(6):42-5. Review.

PMID:
18616021
7.

Systematic review with meta-analysis: malignancies with anti-tumour necrosis factor-α therapy in inflammatory bowel disease.

Williams CJ, Peyrin-Biroulet L, Ford AC.

Aliment Pharmacol Ther. 2014 Mar;39(5):447-58. doi: 10.1111/apt.12624. Epub 2014 Jan 20. Review.

8.

Anti TNF-alpha treatment for Crohn' disease: "ménage a trois".

Danese S.

Curr Drug Targets. 2010 Feb;11(2):136-7. No abstract available.

PMID:
20214597
9.

The association of psoriasiform rash with anti-tumor necrosis factor (anti-TNF) therapy in inflammatory bowel disease: a single academic center case series.

Afzali A, Wheat CL, Hu JK, Olerud JE, Lee SD.

J Crohns Colitis. 2014 Jun;8(6):480-8. doi: 10.1016/j.crohns.2013.10.013. Epub 2013 Nov 21.

PMID:
24268978
10.

Tumor necrosis factor-α monoclonal antibodies in the treatment of inflammatory bowel disease: clinical practice pharmacology.

Lee TW, Fedorak RN.

Gastroenterol Clin North Am. 2010 Sep;39(3):543-57. doi: 10.1016/j.gtc.2010.08.018. Review.

PMID:
20951917
11.

Anti-TNF-alpha treatment strategies: results and clinical perspectives.

D'Haens G.

Gastroenterol Clin Biol. 2009 Jun;33 Suppl 3:S209-16. doi: 10.1016/S0399-8320(09)73156-2.

12.

TNF inhibitors for Crohn's disease: when, which, and for how long.

[No authors listed]

Med Lett Drugs Ther. 2013 Dec 23;55(1432):102-3. No abstract available.

PMID:
24419244
13.

Drug insight: antagonists of tumor-necrosis factor-alpha in the treatment of inflammatory bowel disease.

Chang JT, Lichtenstein GR.

Nat Clin Pract Gastroenterol Hepatol. 2006 Apr;3(4):220-8. Review.

PMID:
16582964
14.

Older age is associated with higher rate of discontinuation of anti-TNF therapy in patients with inflammatory bowel disease.

Desai A, Zator ZA, de Silva P, Nguyen DD, Korzenik J, Yajnik V, Ananthakrishnan AN.

Inflamm Bowel Dis. 2013 Feb;19(2):309-15. doi: 10.1002/ibd.23026.

15.

Certolizumab (Cimzia) for Crohn's disease.

[No authors listed]

Med Lett Drugs Ther. 2008 Oct 20;50(1297):81-2. No abstract available.

PMID:
18927521
16.

Role of the tumor necrosis factor antagonists in the treatment of inflammatory bowel disease: an update.

Leso V, Leggio L, Armuzzi A, Gasbarrini G, Gasbarrini A, Addolorato G.

Eur J Gastroenterol Hepatol. 2010 Jul;22(7):779-86. doi: 10.1097/MEG.0b013e328331b654. Review.

PMID:
19786877
17.

Mucosal healing and anti TNFs in IBD.

van Assche G, Vermeire S, Rutgeerts P.

Curr Drug Targets. 2010 Feb;11(2):227-33.

PMID:
20210770
19.

Letter: tumour necrosis factor alpha blocker switching--a not so simple pharmacokinetic.

Licinio R, Losurdo G, Ierardi E, Di Leo A, Principi M.

Aliment Pharmacol Ther. 2015 Jun;41(12):1302. doi: 10.1111/apt.13212. No abstract available.

PMID:
25968153
20.

Anti-TNF therapy in inflammatory bowel diseases: a huge review.

Peyrin-Biroulet L.

Minerva Gastroenterol Dietol. 2010 Jun;56(2):233-43. Review.

PMID:
20485259
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk